{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:27:01Z","timestamp":1786598821776,"version":"build-2736575974"},"reference-count":180,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016361","name":"Asociaci\u00f3n Colombiana de Infectolog\u00eda","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016361","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/0431fz439","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Fungi","JoF"],"abstract":"<jats:p>Invasive fungal infections (IFIs) are associated with high morbidity and mortality, particularly in immunocompromised or critically ill patients and in those with complex comorbidities. Despite advances in mycological diagnosis and antifungal therapy, outcomes remain poor in a significant proportion of patients. In clinical practice, a poor response is often attributed to microbiological resistance. This interpretation may lead to empirical treatment escalation, combination therapy without a clear indication, increased toxicity, clinically relevant drug\u2013drug interactions, and inefficient use of healthcare resources. However, therapeutic failure rarely results from a single mechanism. More often, it reflects the interaction among host vulnerability, pathogen characteristics, delayed, incomplete, or incorrect diagnosis, insufficient antifungal exposure, and inadequate source control. This narrative review presents a structured clinical approach to evaluating suboptimal responses in IFIs without attributing them solely to antifungal resistance. It examines cross-cutting determinants and specific patterns associated with invasive aspergillosis, invasive candidiasis and persistent candidemia, cryptococcal meningitis, mucormycosis, infections caused by rare filamentous fungi, and disseminated endemic mycoses. It also presents clinical algorithms, checklists, and potential quality indicators to distinguish true from apparent failure, identify modifiable factors, and support transparent clinical decision-making within antifungal stewardship programs. The proposed framework supports the assessment of non-response through systematic diagnostic and therapeutic reassessment, timely source control, and identification of modifiable gaps in care.<\/jats:p>","DOI":"10.3390\/jof12080596","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:51:36Z","timestamp":1786449096000},"page":"596","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance\u2014A Narrative Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-3182","authenticated-orcid":false,"given":"Pilar","family":"Rivas-Pinedo","sequence":"first","affiliation":[{"name":"Medical and Diagnostic Mycology Group, Department of Microbiology, Faculty of Medicine, Universidad Nacional de Colombia, Bogot\u00e1 111321, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-792X","authenticated-orcid":false,"given":"Jos\u00e9 Mill\u00e1n","family":"O\u00f1ate Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"One Health Research Group for Infectious Diseases, Keralty, Department of Internal Medicine, Cl\u00ednica Colsanitas S.A., Cl\u00ednica Sebasti\u00e1n de Belalc\u00e1zar, Cali 760045, Colombia"},{"name":"Clinical Research and Education Group (GIEDCO), Cl\u00ednica de Occidente, Cali 760035, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","unstructured":"World Health Organization (2022). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmi.2024.08.006","article-title":"Invasive fungal disease in the immunocompromised host: Changing epidemiology, new antifungal therapies, and management challenges","volume":"31","author":"Giannella","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global Guideline for the Diagnosis and Management of Rare Mould Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","article-title":"Global guideline for the diagnosis and management of the endemic mycoses: An initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology","volume":"21","author":"Thompson","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/587101","article-title":"When primary antifungal therapy fails","volume":"46","author":"Nucci","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: Prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e14175","DOI":"10.1111\/tid.14175","article-title":"Challenges in management of invasive fungal infections in stem cell transplant","volume":"25","author":"Walker","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/myc.13148","article-title":"Breakthrough invasive fungal infections: Who is at risk?","volume":"63","author":"Jenks","year":"2020","journal-title":"Mycoses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14740338.2021.1922667","article-title":"Antifungal agents and the kidney: Pharmacokinetics, clinical nephrotoxicity, and interactions","volume":"20","author":"Tragiannidis","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_11","first-page":"149","article-title":"Clinical hepatotoxicity associated with antifungal agents","volume":"16","author":"Kyriakidis","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2352-3026(21)00232-5","article-title":"Management of drug\u2013drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs","volume":"9","author":"Verheggen","year":"2022","journal-title":"Lancet Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jac\/dkae103","article-title":"Triazole antifungal drug interactions-practical considerations for excellent prescribing","volume":"79","author":"Lewis","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: An initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"24","author":"Chang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"for the Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM). Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/dky517","article-title":"Emerging threat of triazole-resistant Aspergillus fumigatus","volume":"74","author":"Rybak","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imj.15586","article-title":"Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021","volume":"51","author":"Khanina","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21505594.2016.1226721","article-title":"Antifungal stewardship considerations for adults and pediatrics","volume":"8","author":"Hamdy","year":"2017","journal-title":"Virulence"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12281-023-00465-1","article-title":"Antifungal Stewardship Interventions in Patients with Hematologic Malignancies","volume":"17","author":"Vergidis","year":"2023","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Procacci, C., Marras, L., Maurmo, L., Vivanet, G., Scalone, L., and Bertolino, G. (2025). Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review. Advances in Microbiology, Infectious Diseases and Public Health, Springer.","DOI":"10.1007\/5584_2024_798"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Albahar, F., Alhamad, H., Abu Assab, M., Abu-Farha, R., Alawi, L., and Khaleel, S. (2023). The Impact of Antifungal Stewardship on Clinical and Performance Measures: A Global Systematic Review. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9010008"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ofac234","DOI":"10.1093\/ofid\/ofac234","article-title":"The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review","volume":"9","author":"Chakrabarti","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: Implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijmmb.2022.07.013","article-title":"Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases","volume":"40","author":"Gupta","year":"2022","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"ofac112","DOI":"10.1093\/ofid\/ofac112","article-title":"Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases","volume":"9","author":"Thompson","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","article-title":"Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis","volume":"4","author":"Donnelly","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QCO.0000000000000937","article-title":"Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: Are we making progress?","volume":"36","author":"Lewis","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/jac\/dkae158","article-title":"Breaking the mould: Challenging the status quo of clinical trial response definitions for invasive fungal diseases\u2014A debate","volume":"79","author":"Maertens","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"myae083","DOI":"10.1093\/mmy\/myae083","article-title":"A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole","volume":"62","author":"Thompson","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Boutin, C.A., and Luong, M.L. (2024). Update on therapeutic approaches for invasive fungal infections in adults. Ther. Adv. Infect. Dis., 11.","DOI":"10.1177\/20499361231224980"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chest.2024.08.046","article-title":"Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host","volume":"167","author":"Wahab","year":"2025","journal-title":"Chest"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Carmo, A., Rocha, M., Pereirinha, P., Tom\u00e9, R., and Costa, E. (2023). Antifungals: From Pharmacokinetics to Clinical Practice. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050884"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QCO.0000000000000740","article-title":"Managing uncertainty in antifungal dosing: Antibiograms, therapeutic drug monitoring and drug-drug interactions","volume":"34","author":"Lewis","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lepak, A.J., and Andes, D.R. (2014). Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harbor Perspectives Medicine, Cold Spring Harbor Laboratory Press.","DOI":"10.1101\/cshperspect.a019653"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mori, G., Diotallevi, S., Farina, F., Lolatto, R., Galli, L., Chiurlo, M., Acerbis, A., Xue, E., Clerici, D., and Mastaglio, S. (2024). High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies. Microorganisms, 12.","DOI":"10.3390\/microorganisms12010117"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1634\/theoncologist.2010-0290","article-title":"Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold Azoles","volume":"16","author":"Ramos","year":"2011","journal-title":"Oncologist"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: A SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12281-023-00456-2","article-title":"The Impact of Corticosteroids on the Outcome of Fungal Disease: A Systematic Review and Meta-analysis","volume":"17","author":"Li","year":"2023","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Neofytos, D., Garcia-Vidal, C., Lamoth, F., Lichtenstern, C., Perrella, A., and Vehreschild, J.J. (2021). Invasive aspergillosis in solid organ transplant patients: Diagnosis, prophylaxis, treatment, and assessment of response. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05958-3"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imj.15587","article-title":"Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021","volume":"51","author":"Chau","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: A Position Paper","volume":"46","author":"Alffenaar","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00134-025-07793-5","article-title":"Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study","volume":"51","author":"Roberts","year":"2025","journal-title":"Intensive Care Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: Guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Alqarihi, A., Kontoyiannis, D.P., and Ibrahim, A.S. (2023). Mucormycosis in 2023: An update on pathogenesis and management. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1254919"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/mmy\/myab044","article-title":"Invasive aspergillosis is a critical determinant of mortality in cirrhosis: A systematic review with meta-analysis","volume":"59","author":"Verma","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104579","DOI":"10.1016\/j.bjid.2025.104579","article-title":"Brazilian task force for the management of mucormycosis","volume":"29","author":"Macedo","year":"2025","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Brienze, V.M.S., Andr\u00e9, J.C., Liso, E., and Vlasova-St. Louis, I. (2021). Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches. Life, 11.","DOI":"10.3390\/life11020095"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e13543","DOI":"10.1111\/ctr.13543","article-title":"Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin. Transpl."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Delli\u00e8re, S., Guery, R., Candon, S., Rammaert, B., Aguilar, C., Lanternier, F., Chatenoud, L., and Lortholary, O. (2018). Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections. J. Fungi, 4.","DOI":"10.3390\/jof4040139"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Antimicrobial resistance: Resistance to antifungal agents: Mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"De Francesco, M.A. (2023). Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe. Pathogens, 12.","DOI":"10.3390\/pathogens12111305"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103243","DOI":"10.1016\/j.fgb.2019.103243","article-title":"Candida auris and multidrug resistance: Defining the new normal","volume":"131","author":"Lockhart","year":"2019","journal-title":"Fungal Genet. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zubovskaia, A. (2025). Azole-Resistant Aspergillus fumigatus: Epidemiology, Diagnosis, and Treatment Considerations. J. Fungi, 11.","DOI":"10.3390\/jof11100731"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMra2311057","article-title":"Cryptococcal Disease in Diverse Hosts","volume":"390","author":"Meya","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: Implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: Analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mercier, T., Wera, J., Chai, L.Y.A., Lagrou, K., and Maertens, J. (2020). A Mortality Prediction Rule for Hematology Patients with Invasive Aspergillosis Based on Serum Galactomannan Kinetics. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020610"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"106629","DOI":"10.1016\/j.jinf.2025.106629","article-title":"Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III study","volume":"91","author":"Sedik","year":"2025","journal-title":"J. Infect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0039424","DOI":"10.1128\/jcm.00394-24","article-title":"Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis","volume":"62","author":"Moreno","year":"2024","journal-title":"J. Clin. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"myae042","DOI":"10.1093\/mmy\/myae042","article-title":"Candida auris\u2014A systematic review to inform the world health organization fungal priority pathogens list","volume":"62","author":"Kim","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11046-014-9774-0","article-title":"Multi-resistant aspergillosis due to cryptic species","volume":"178","author":"Howard","year":"2014","journal-title":"Mycopathologia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.riam.2022.04.002","article-title":"Aspergillosis by cryptic Aspergillus species: A case series and review of the literature","volume":"39","author":"Cardozo","year":"2022","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Jacobs, S.E., and Walsh, T.J. (2023). Non-Aspergillus Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases. J. Fungi, 9.","DOI":"10.3390\/jof9020212"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4014\/jmb.2404.04040","article-title":"Comprehensive Overview of Candida auris: An Emerging Multidrug-Resistant Fungal Pathogen","volume":"34","author":"Kim","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hsu, C., and Yassin, M. (2025). Diagnostic Approaches for Candida auris: A Comprehensive Review of Screening, Identification, and Susceptibility Testing. Microorganisms, 13.","DOI":"10.20944\/preprints202505.1232.v1"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"myad128","DOI":"10.1093\/mmy\/myad128","article-title":"Fusarium species, Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens","volume":"62","author":"Marinelli","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00203-024-04026-z","article-title":"Azole resistance in Aspergillus fumigatus- comprehensive review","volume":"206","author":"Dladla","year":"2024","journal-title":"Arch. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JCM.01070-09","article-title":"Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Balajee","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Denning, D.W. (2024). Renaming Candida glabrata\u2014A case of taxonomic purity over clinical and public health pragmatism. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012055"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e01530-25","DOI":"10.1128\/jcm.01530-25","article-title":"Beyond Candidiasis: Should Infections Caused by Candidozyma auris Be Renamed?","volume":"64","year":"2026","journal-title":"J. Clin. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"dlaf106","DOI":"10.1093\/jacamr\/dlaf106","article-title":"Understanding the mechanisms of resistance to azole antifungals in Candida species","volume":"7","author":"Li","year":"2025","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e0000423","DOI":"10.1128\/cmr.00004-23","article-title":"Scedosporiosis and lomentosporiosis: Modern perspectives on these difficult-to-treat rare mold infections","volume":"37","author":"Neoh","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Chen, S.C.A., Halliday, C.L., Hoenigl, M., Cornely, O.A., and Meyer, W. (2021). Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease. J. Fungi, 7.","DOI":"10.3390\/jof7010023"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"102237","DOI":"10.1016\/j.mib.2022.102237","article-title":"Antifungal drug-resistance mechanisms in Candida biofilms","volume":"71","author":"Kaur","year":"2023","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics4010001","article-title":"The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia","volume":"4","author":"Bouza","year":"2014","journal-title":"Antibiotics"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2217\/fmb.13.101","article-title":"Mechanisms of Candida biofilm drug resistance","volume":"8","author":"Taff","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(18)30030-9","article-title":"Advances in the diagnosis and treatment of fungal infections of the CNS","volume":"17","author":"Schwartz","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Vergidis, P., Clancy, C.J., Shields, R.K., Park, S.Y., Wildfeuer, B.N., Simmons, R.L., and Nguyen, M.H. (2016). Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153247"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13054-023-04742-w","article-title":"Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis","volume":"27","author":"Novy","year":"2023","journal-title":"Crit. Care"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"myad021","DOI":"10.1093\/mmy\/myad021","article-title":"Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections","volume":"61","author":"Chumbita","year":"2023","journal-title":"Med. Mycol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: Challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","article-title":"Antifungal therapeutic drug monitoring: Focus on drugs without a clear recommendation","volume":"26","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: Importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"ofad389","DOI":"10.1093\/ofid\/ofad389","article-title":"Low Rates of Antifungal Therapeutic Drug Monitoring Among Inpatients Who Received Itraconazole, Posaconazole, or Voriconazole, United States, 2019-2021","volume":"10","author":"Benedict","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Pais, M.M., Zaragoza, R., Mart\u00edn-Loeches, I., G\u00f3mez-Bertomeu, F.F., and Rodr\u00edguez, A. (2025). Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review. J. Fungi, 11.","DOI":"10.20944\/preprints202503.0464.v1"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"454","DOI":"10.37201\/req\/095.2025","article-title":"Review on the management of intra-abdominal candidiasis","volume":"38","author":"Guinea","year":"2025","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/mmy\/myy067","article-title":"Beyond tissue concentrations: Antifungal penetration at the site of infection","volume":"57","author":"Zhao","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s13054-025-05697-w","article-title":"Factors affecting voriconazole pharmacokinetic variability in critically ill patients: A systematic review","volume":"29","author":"Coste","year":"2025","journal-title":"Crit. Care"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"107078","DOI":"10.1016\/j.ijantimicag.2023.107078","article-title":"The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review","volume":"63","author":"Jendoubi","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Alffenaar","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/14787210.2024.2403017","article-title":"Diagnosing fungal infections in clinical practice: A narrative review","volume":"22","author":"Sedik","year":"2024","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Azim, A., and Ahmed, A. (2024). Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: A comprehensive review. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1256158"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.00053-10","article-title":"Histopathologic diagnosis of fungal infections in the 21st century","volume":"24","author":"Guarner","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing","volume":"61","author":"White","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2012.761134","article-title":"Fungal diagnosis: How do we do it and can we do better?","volume":"29","author":"Perfect","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Jenks, J.D., Gangneux, J.P., Schwartz, I.S., Alastruey-Izquierdo, A., Lagrou, K., Thompson, G.R., Lass-Fl\u00f6rl, C., Hoenigl, M., and European Confederation of Medical Mycology (ECMM) Council Investigators (2020). Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement. J. Fungi, 6.","DOI":"10.20944\/preprints202008.0672.v1"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cmi.2023.05.012","article-title":"How to use direct microscopy for diagnosing fungal infections","volume":"29","author":"Knoll","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Lamoth, F., Lewis, R.E., and Kontoyiannis, D.P. (2020). Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections. J. Fungi, 7.","DOI":"10.3390\/jof7010017"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e00069-19","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal Susceptibility Testing: Current Approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Marinach-Patrice, C., Fekkar, A., Atanasova, R., Gomes, J., Djamdjian, L., Brossas, J.Y., Meyer, I., Buffet, P., Snounou, G., and Datry, A. (2010). Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008862"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cll.2021.03.006","article-title":"MALDI-TOF for Fungal Identification","volume":"41","author":"Lau","year":"2021","journal-title":"Clin. Lab. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"220114","DOI":"10.1183\/16000617.0114-2022","article-title":"Pulmonary aspergillosis: Diagnosis and treatment","volume":"31","author":"Lamoth","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Anaru-Iliescu, B., Mares, M., Vrioni, G., Vyzantiadis, T.A., Montesinos, I., and Rodriguez-Villalobos, H. (2026). Biomarkers in Invasive Pulmonary Fungal Infections: Where Do We Stand?. J. Fungi, 12.","DOI":"10.3390\/jof12020104"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Mercier, T., Guldentops, E., Lagrou, K., and Maertens, J. (2018). Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00661"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0039-3401990","article-title":"Invasive Pulmonary Aspergillosis","volume":"41","author":"Ledoux","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"(1,3)-\u03b2-D-glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1310\/NQXR-ULMG-MM1B-3T2B","article-title":"Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease","volume":"1","author":"Aberg","year":"2000","journal-title":"HIV Clin. Trials"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e01238-18","DOI":"10.1128\/JCM.01238-18","article-title":"Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing","volume":"57","author":"Rajasingham","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Nacher, M., Blanchet, D., Bongomin, F., Chakrabarti, A., Couppi\u00e9, P., Demar, M., Denning, D.W., Djossou, F., Epelboin, L., and Govender, N. (2018). Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006802"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Perez, F., Caceres, D.H., Ford, N., Ravasi, G., Gomez, B.L., Pasqualotto, A.C., Hine, P., Adenis, A.A., Nacher, M., and Chiller, T. (2021). Summary of Guidelines for Managing Histoplasmosis among People Living with HIV. J. Fungi, 7.","DOI":"10.3390\/jof7020134"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CVI.00389-10","article-title":"Histoplasma Antigen Clearance during Treatment of Histoplasmosis in Patients with AIDS Determined by a Quantitative Antigen Enzyme Immunoassay","volume":"18","author":"Hage","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/myc.13023","article-title":"Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS","volume":"63","author":"Chiller","year":"2020","journal-title":"Mycoses"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3201\/eid3008.231710","article-title":"Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa","volume":"30","author":"Sekar","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14737159.2023.2267977","article-title":"An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections","volume":"23","author":"Jenks","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Pham, D., Sivalingam, V., Tang, H.M., Montgomery, J.M., Chen, S.C.A., and Halliday, C.L. (2024). Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches. J. Fungi, 10.","DOI":"10.3390\/jof10070447"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Brown, L., Cruciani, M., Morton, C.O., Alanio, A., Barnes, R.A., Donnelly, J.P., Hagen, F., Gorton, R., Lackner, M., and Loeffler, J. (2025). The Molecular Diagnosis of Invasive Fungal Diseases with a Focus on PCR. Diagnostics, 15.","DOI":"10.3390\/diagnostics15151909"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sabino, R., and Wiederhold, N. (2022). Diagnosis from Tissue: Histology and Identification. J. Fungi, 8.","DOI":"10.3390\/jof8050505"},{"key":"ref_146","first-page":"CD011195","article-title":"Central venous catheter (CVC) removal for patients of all ages with candidaemia","volume":"2016","author":"Janum","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijid.2018.09.016","article-title":"Outcomes in patients with fungal endocarditis: A multicenter observational cohort study","volume":"77","author":"Siciliano","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10096-016-2775-9","article-title":"Association between source control and mortality in 258 patients with intra-abdominal candidiasis: A retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain","volume":"36","author":"Lagunes","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00268-020-05380-x","article-title":"Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis","volume":"44","author":"Yan","year":"2020","journal-title":"World J. Surg."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12224","article-title":"The role of surgical debridement in different clinical manifestations of invasive aspergillosis","volume":"57","author":"Reischies","year":"2014","journal-title":"Mycoses"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CMR.17.2.255-267.2004","article-title":"Candida infections of medical devices","volume":"17","author":"Kojic","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/myc.13049","article-title":"Candida biofilm production is associated with higher mortality in patients with candidaemia","volume":"63","author":"Nagy","year":"2020","journal-title":"Mycoses"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Tumbarello, M., Fiori, B., Trecarichi, E.M., Posteraro, P., Losito, A.R., de Luca, A., Sanguinetti, M., Fadda, G., Cauda, R., and Posteraro, B. (2012). Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033705"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Gamaletsou, M.N., Rammaert, B., Brause, B., Bueno, M.A., Dadwal, S.S., Henry, M.W., Katragkou, A., Kontoyiannis, D.P., McCarthy, M.W., and Miller, A.O. (2022). Osteoarticular Mycoses. Clin. Microbiol. Rev., 35.","DOI":"10.1128\/cmr.00086-19"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijid.2020.01.049","article-title":"Clinical characteristics and risk factors for complications of candidaemia in adults: Focus on endophthalmitis, endocarditis, and osteoarticular infections","volume":"93","author":"Shin","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4330\/wjc.v15.i10.469","article-title":"Candida endocarditis: Update on management considerations","volume":"15","author":"Jamil","year":"2023","journal-title":"World J. Cardiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1111\/j.1600-6143.2009.02909.x","article-title":"Candida in solid organ transplant recipients","volume":"9","author":"Pappas","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","article-title":"Neglected endemic mycoses","volume":"17","author":"Fahal","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0035-1562899","article-title":"Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management","volume":"36","author":"Hage","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: A randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Shi, Z.W., Chen, Y., Ogoke, K.M., Strickland, A.B., and Shi, M. (2022). Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Clinical Studies to Animal Experiments. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122419"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","article-title":"Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports","volume":"53","author":"Jeong","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Ledoux, M.P., Dicop, E., Sabou, M., Letscher-Bru, V., Castelain, V., Danion, F., Candolfi, E., Herbrecht, R., Lortholary, O., and Lamoth, F. (2024). Fusarium, Scedosporium and Other Rare Mold Invasive Infections: Over Twenty-Five-Year Experience of a European Tertiary-Care Center. J. Fungi, 10.","DOI":"10.3390\/jof10040289"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2217\/fmb.13.63","article-title":"Rasamsonia argillacea species complex: Taxonomy, pathogenesis and clinical relevance","volume":"8","author":"Giraud","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jac\/dkab039","article-title":"Invasive infections with Purpureocillium lilacinum: Clinical characteristics and outcome of 101 cases from FungiScope\u00ae and the literature","volume":"76","author":"Sprute","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jac\/dkaa481","article-title":"Characterization and outcome of invasive infections due to Paecilomyces variotii: Analysis of patients from the FungiScope\u00ae registry and literature reports","volume":"76","author":"Sprute","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_170","unstructured":"Pan American Health Organization, and World Health Organization (2020). Guidelines for Diagnosing and Managing Disseminated Histoplasmosis Among People Living with HIV, Pan American Health Organization. Available online: https:\/\/www.paho.org\/en\/node\/71472."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/0037-8682-0230-2017","article-title":"Brazilian guidelines for the clinical management of paracoccidioidomycosis","volume":"50","author":"Mendes","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"C\u00e1ceres, D.H., G\u00f3mez, B.L., Tob\u00f3n, \u00c1.M., Restrepo, \u00c1., Chiller, T., Lindsley, M.D., Meis, J.F., and Verweij, P.E. (2023). Tackling Histoplasmosis Infection in People Living with HIV from Latin America: From Diagnostic Strategy to Public Health Solutions. J. Fungi, 9.","DOI":"10.3390\/jof9050558"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S2352-3018(26)00006-8","article-title":"Histoplasmosis: A missing piece in the global efforts to end HIV deaths","volume":"13","author":"Pasqualotto","year":"2026","journal-title":"Lancet HIV"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Baracaldo-Santamar\u00eda, D., Cala-Garcia, J.D., Medina-Rinc\u00f3n, G.J., Rojas-Rodriguez, L.C., and Calderon-Ospina, C.A. (2022). Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050645"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12941-019-0323-z","article-title":"A systematic review of the impact of antifungal stewardship interventions in the United States","volume":"18","author":"Hart","year":"2019","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10096-019-03600-4","article-title":"Essential in vitro diagnostics for advanced HIV and serious fungal diseases: International experts\u2019 consensus recommendations","volume":"38","author":"Bongomin","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0036-46652015000700010","article-title":"The Treatment of Coccidioidomycosis","volume":"57","author":"Ampel","year":"2015","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Schwartz, I.S., Govender, N.P., Sigler, L., Jiang, Y., Maphanga, T.G., Toplis, B., Botha, A., Dukik, K., Hoving, J.C., and Mu\u00f1oz, J.F. (2019). Emergomyces: The global rise of new dimorphic fungal pathogens. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007977"},{"key":"ref_180","unstructured":"World Health Organization (2025). Landscape Analysis of Commercially Available and Pipeline In Vitro Diagnostics for Fungal Priority Pathogens, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240105539."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/8\/596\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:30:57Z","timestamp":1786595457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/8\/596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":180,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jof12080596"],"URL":"https:\/\/doi.org\/10.3390\/jof12080596","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}